Dynamin inhibition interferes with inflammasome activation and cytokine gene expression in Streptococcus pyogenes-infected human macrophages

Clinical and Experimental Immunology

Volumn 178, Issue 2, 2014, Pages 320-333

  Latvala, S ^a   Makela S M ^a   Miettinen, M ^b   Charpentier, E ^d   Julkunen, I ^a,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b VALIO LTD   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cytokine; Gene regulation; Inflammasome; Innate immunity; Signal transduction

Indexed keywords

AUTACOID; CARRIER PROTEIN; CYTOKINE; DYNAMIN; INFLAMMASOME; MESSENGER RNA; NLRP3 PROTEIN, HUMAN;

BIOSYNTHESIS; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

CARRIER PROTEINS; CYTOKINES; DYNAMINS; ENDOCYTOSIS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION MEDIATORS; MACROPHAGES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84908181381     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12425     Document Type: Article

References (58)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-694.
2. Ralph AP, Carapetis JR. Group A streptococcal diseases and their global burden. Curr Top Microbiol Immunol 2013; 368:1-27.
3. Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 2011; 9:724-736.
4. Kwinn LA, Nizet V. How group A Streptococcus circumvents host phagocyte defenses. Future Microbiol 2007; 2:75-84.
5. Hertzen E, Johansson L, Wallin R etal. M1 protein-dependent intracellular trafficking promotes persistence and replication of Streptococcus pyogenes in macrophages. J Innate Immun 2010; 2:534-545.
6. Maloy KJ. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med 2008; 263:584-590.
7. Alouf JE. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther 1980; 11:661-717.
8. Nizet V. Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol 2002; 10:575-580.
9. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76:509-513.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
11. Gratz N, Siller M, Schaljo B etal. Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chem 2008; 283:19879-19887.
12. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27:229-265.
13. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: beyond the inflammasomes. PLOS Pathog 2010; 6:e1000661.
14. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 1998; 856:1-11.
15. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998; 161:3340-3346.
16. Netea MG, Nold-Petry CA, Nold MF etal. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009; 113:2324-2335.
17. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol 2000; 164:3733-3740.
18. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007; 82:710-720.
19. Latvala S, Pietila TE, Veckman V etal. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 2008; 14:5570-5583, discussion 5581-2.
20. Latvala S, Miettinen M, Kekkonen RA, Korpela R, Julkunen I. Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol 2011; 165:94-103.
21. Pietila TE, Latvala S, Osterlund P, Julkunen I. Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs. J Leukoc Biol 2010; 88:665-674.
22. Makela SM, Osterlund P, Julkunen I. TLR ligands induce synergistic interferon-beta and interferon-lambda1 gene expression in human monocyte-derived dendritic cells. Mol Immunol 2011; 48:505-515.
23. Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009; 85:664-672.
24. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006; 10:839-850.
25. Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol 2008; 438:77-93.
26. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64:5403-5405.
27. Pirhonen J, Sareneva T, Julkunen I, Matikainen S. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur J Immunol 2001; 31:726-733.
28. Sillanpaa M, Kaukinen P, Melen K, Julkunen I. Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression. J Gen Virol 2008; 89:432-443.
29. Gratz N, Hartweger H, Matt U etal. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLOS Pathog 2011; 7:e1001345.
30. Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, Nunez G. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 2009; 183:5823-5829.
31. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006; 124:729-740.
32. Claudinon J, Monier MN, Lamaze C. Interfering with interferon receptor sorting and trafficking: impact on signaling. Biochimie 2007; 89:735-743.
33. Molloy EM, Cotter PD, Hill C, Mitchell DA, Ross RP. Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol 2011; 9:670-681.
34. Goldmann O, Rohde M, Chhatwal GS, Medina E. Role of macrophages in host resistance to group A streptococci. Infect Immun 2004; 72:2956-2963.
35. Thulin P, Johansson L, Low DE etal. Viable group A streptococci in macrophages during acute soft tissue infection. PLOS Med 2006; 3:e53.
36. LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91:12115-12119.
37. Rohde M, Muller E, Chhatwal GS, Talay SR. Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol 2003; 5:323-342.
38. Staali L, Morgelin M, Bjorck L, Tapper H. Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 2003; 5:253-265.
39. Veckman V, Miettinen M, Pirhonen J, Siren J, Matikainen S, Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004; 75:764-771.
40. Miettinen M, Pietila TE, Kekkonen RA etal. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes 2012; 3:510-522.
41. Nakagawa I, Amano A, Mizushima N etal. Autophagy defends cells against invading group A Streptococcus. Science 2004; 306:1037-1040.
42. Hakansson A, Bentley CC, Shakhnovic EA, Wessels MR. Cytolysin-dependent evasion of lysosomal killing. Proc Natl Acad Sci USA 2005; 102:5192-5197.
43. Freche B, Reig N, van der Goot FG. The role of the inflammasome in cellular responses to toxins and bacterial effectors. Semin Immunopathol 2007; 29:249-260.
44. Mariathasan S, Weiss DS, Newton K etal. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228-232.
45. Coeshott C, Ohnemus C, Pilyavskaya A etal. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999; 96:6261-6266.
46. Kayagaki N, Wong MT, Stowe IB etal. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013; 341:1246-1249.
47. Pahlman LI, Morgelin M, Eckert J etal. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006; 177:1221-1228.
48. Parker D, Prince A. Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol 2012; 189:4040-4046.
49. Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009; 10:1200-1207.
50. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008; 9:361-368.
51. Stockinger S, Materna T, Stoiber D etal. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 2002; 169:6522-6529.
52. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006; 25:349-360.
53. Stockinger S, Reutterer B, Schaljo B etal. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol 2004; 173:7416-7425.
54. O'Riordan M, Yi CH, Gonzales R, Lee KD, Portnoy DA. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc Natl Acad Sci USA 2002; 99:13861-13866.
55. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006; 24:93-103.
56. Park JM, Ng VH, Maeda S, Rest RF, Karin M. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med 2004; 200:1647-1655.
57. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 2007; 8:603-612.
58. Bonazzi M, Cossart P. Bacterial entry into cells: a role for the endocytic machinery. FEBS Lett 2006; 580:2962-2967.